Simon Baker
Stock Analyst at Redburn Atlantic
(0.35)
# 3,977
Out of 4,814 analysts
8
Total ratings
25%
Success rate
-11.99%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $1.43 | +809.09% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $98.76 | +72.13% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $40.72 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $129.70 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $57.55 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $47.93 | -49.93% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $1.43
Upside: +809.09%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $98.76
Upside: +72.13%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $40.72
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $129.70
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $57.55
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $47.93
Upside: -49.93%